CAZZANIGA, GIOVANNI
CAZZANIGA, GIOVANNI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement
2022 Bomken, S; Enshaei, A; Schwalbe, E; Mikulasova, A; Dai, Y; Zaka, M; Fung, K; Bashton, M; Lim, H; Jones, L; Karataraki, N; Winterman, E; Ashby, C; Attarbaschi, A; Bertrand, Y; Bradtke, J; Buldini, B; Burke, G; Cazzaniga, G; Gohring, G; De Groot-Kruseman, H; Haferlach, C; Nigro, L; Parihar, M; Plesa, A; Seaford, E; Sonneveld, E; Strehl, S; Van der Velden, V; Rand, V; Hunger, S; Harrison, C; Bacon, C; Van Delft, F; Loh, M; Moppett, J; Vormoor, J; Walker, B; Moorman, A; Russell, L
Minimal Residual Disease Analysis by Monitoring Immunoglobulin and T-Cell Receptor Gene Rearrangements by Quantitative PCR and Droplet Digital PCR
2022 Starza, I; Eckert, C; Drandi, D; Cazzaniga, G
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium
2022 Buchmann, S; Schrappe, M; Baruchel, A; Biondi, A; Borowitz, M; Campbell, M; Cario, G; Cazzaniga, G; Escherich, G; Harrison, C; Heyman, M; Hunger, S; Kiss, C; Liu, H; Locatelli, F; Loh, M; Manabe, A; Mann, G; Pieters, R; Pui, C; Rives, S; Schmiegelow, K; Silverman, L; Stary, J; Vora, A; Brown, P
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
2022 Ramos-Muntada, M; Trincado, J; Blanco, J; Bueno, C; Rodriguez-Cortez, V; Bataller, A; Lopez-Millan, B; Schwab, C; Ortega, M; Velasco, P; Blanco, M; Nomdedeu, J; Ramirez-Orellana, M; Minguela, A; Fuster, J; Cuatrecasas, E; Camos, M; Ballerini, P; Escherich, G; Boer, J; Denboer, M; Hernandez-Rivas, J; Calasanz, M; Cazzaniga, G; Harrison, C; Menendez, P; Molina, O
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
2022 Kulp, M; Siemund, A; Larghero, P; Dietz, A; Alten, J; Cario, G; Eckert, C; Caye-Eude, A; Cave, H; Bardini, M; Cazzaniga, G; De Lorenzo, P; Valsecchi, M; Diehl, L; Bonig, H; Meyer, C; Marschalek, R
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL Syndrome
2022 Saettini, F; Coliva, T; Vendemini, F; Galbiati, M; Bugarin, C; Masetti, R; Moratto, D; Chiarini, M; Guerra, F; Iascone, M; Badolato, R; Cazzaniga, G; Niemeyer, C; Flotho, C; Biondi, A
Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse
2022 Antic, Z; Yu, J; Bornhauser, B; Lelieveld, S; van der Ham, C; van Reijmersdal, S; Morgado, L; Elitzur, S; Bourquin, J; Cazzaniga, G; Eckert, C; Camos, M; Sutton, R; Cave, H; Moorman, A; Sonneveld, E; Geurts van Kessel, A; van Leeuwen, F; Hoogerbrugge, P; Waanders, E; Kuiper, R
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)
2022 Locatelli, F; Lo Nigro, L; Andriano, N; Buldini, B; Silvestri, D; Villa, T; Parasole, R; Barisone, E; Testi, A; Biondi, A; Valsecchi, M; Rizzari, C; Conter, V; Basso, G; Cazzaniga, G
Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia
2022 Severgnini, M; D'Angiò, M; Bungaro, S; Cazzaniga, G; Cifola, I; Fazio, G
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis
2022 Pezzotta, A; Gentile, I; Genovese, D; Totaro, M; Battaglia, C; Leung, A; Fumagalli, M; Parma, M; Cazzaniga, G; Fazio, G; Alcalay, M; Marozzi, A; Pistocchi, A
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
2022 Zuna, J; Hovorkova, L; Krotka, J; Koehrmann, A; Bardini, M; Winkowska, L; Fronkova, E; Alten, J; Koehler, R; Eckert, C; Brizzolara, L; Trkova, M; Stuchly, J; Zimmermann, M; De Lorenzo, P; Valsecchi, M; Conter, V; Stary, J; Schrappe, M; Biondi, A; Trka, J; Zaliova, M; Cazzaniga, G; Cario, G
Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies
2022 Saitta, C; Rebellato, S; Bettini, L; Giudici, G; Panini, N; Erba, E; Massa, V; Auer, F; Friedrich, U; Hauer, J; Biondi, A; Fazio, G; Cazzaniga, G
Identical EP300 variant leading to Rubinstein–Taybi syndrome with different clinical and immunologic phenotype
2022 Saettini, F; Fazio, G; Bonati, M; Moratto, D; Massa, V; Di Fede, E; Castiglioni, S; Marchetti, D; Chiarini, M; Sottini, A; Iascone, M; Cazzaniga, G; Imberti, L; Biondi, A; Gervasini, C; Badolato, R
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
2022 Fazio, G; Bresolin, S; Silvestri, D; Quadri, M; Saitta, C; Vendramini, E; Buldini, B; Palmi, C; Bardini, M; Grioni, A; Rigamonti, S; Galbiati, M; Mecca, S; Savino, A; Peloso, A; Tu, J; Bhatia, S; Borkhardt, A; Micalizzi, C; Lo Nigro, L; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Te Kronnie, G; Biondi, A; Cazzaniga, G
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol
2022 Stutterheim, J; de Lorenzo, P; van der Sluin, I; Alten, J; Ancliffe, P; Attarbaschi, A; Aversa, L; Boer, J; Biondi, A; Brethon, B; Diaz, P; Cazzaniga, G; Escherich, G; Ferster, A; Kotecha, R; Lausen, B; Leung, A; Locatelli, F; Silverman, L; Stary, J; Szczepanski, T; van der Velden, V; Vora, A; Zuna, J; Schrappe, M; Valsecchi, M; Pieters, R
Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma
2022 Schedel, A; Friedrich, U; Morcos, M; Wagener, R; Mehtonen, J; Watrin, T; Saitta, C; Brozou, T; Michler, P; Walter, C; Forsti, A; Baksi, A; Menzel, M; Horak, P; Paramasivam, N; Fazio, G; Autry, R; Frohling, S; Suttorp, M; Gertzen, C; Gohlke, H; Bhatia, S; Wadt, K; Schmiegelow, K; Dugas, M; Richter, D; Glimm, H; Heinaniemi, M; Jessberger, R; Cazzaniga, G; Borkhardt, A; Hauer, J; Auer, F
The bone marrow niche in b-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia
2021 Dander, E; Palmi, C; D'Amico, G; Cazzaniga, G
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
2021 Boer, J; Valsecchi, M; Hormann, F; Antic, Z; Zaliova, M; Schwab, C; Cazzaniga, G; Arfeuille, C; Cave, H; Attarbaschi, A; Strehl, S; Escherich, G; Imamura, T; Ohki, K; Gruber, T; Sutton, R; Pastorczak, A; Lammens, T; Lambert, F; Li, C; Carrillo de Santa Pau, E; Hoffmann, S; Moricke, A; Harrison, C; Den Boer, M; De Lorenzo, P; Stam, R; Bergmann, A; Pieters, R
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
2021 Turati, V; Guerra-Assuncao, J; Potter, N; Gupta, R; Ecker, S; Daneviciute, A; Tarabichi, M; Webster, A; Ding, C; May, G; James, C; Brown, J; Conde, L; Russell, L; Ancliff, P; Inglott, S; Cazzaniga, G; Biondi, A; Hall, G; Lynch, M; Hubank, M; Macaulay, I; Beck, S; Van Loo, P; Jacobsen, S; Greaves, M; Herrero, J; Enver, T
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
2021 Della Starza, I; Nunes, V; Lovisa, F; Silvestri, D; Cavalli, M; Garofalo, A; Campeggio, M; De Novi, L; Soscia, R; Oggioni, C; Mussolin, L; Biondi, A; Guarini, A; Valsecchi, M; Conter, V; Biffi, A; Basso, G; Foà, R; Cazzaniga, G